NASDAQ

Pulmonx Corporation (LUNG)

383 Thanks from members

Pulmonx Corporation (LUNG) exhibits a recovering market narrative characterized by narrowing losses, record gross margins, and strategic sales force reorganization, though offset by temporary top-line declines tied to the suspension of sales in China.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →